Abstract
Evidence has shown that gut microbiome plays a role in modulating the development of diseases beyond the gastrointestinal tract, including skin disorders such as psoriasis. The gut–skin axis refers to the bidirectional relationship between the gut microbiome and skin health. This is regulated through several mechanisms such as inflammatory mediators and the immune system. Dysregulation of microbiota has been seen in numerous inflammatory skin conditions such as atopic dermatitis, rosacea, and psoriasis. Understanding how gut microbiome are involved in regulating skin health may lead to development of novel therapies for these skin disorders through microbiome modulation, in particularly psoriasis. In this review, we will compare the microbiota between psoriasis patients and healthy control, explain the concept of gut–skin axis and the effects of gut dysbiosis on skin physiology. We will also review the current evidence on modulating gut microbiome using probiotics in psoriasis.
Funder
Jeffrey Cheah School of Medicine and Health Sciences Strategic Grant 2021
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference194 articles.
1. Global Report on Psoriasis,2016
2. Global Burden of Disease Study 2010: Results by Cause 1990–2010
https://ghdx.healthdata.org/record/ihme-data/gbd-2010-results-cause-1990-2010
3. Etiology and Pathogenesis of Psoriatic Arthritis
4. Etiology and Pathogenesis of Psoriasis
5. IL-12 protects from psoriasiform skin inflammation
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献